<?xml version="1.0" encoding="utf-8"?>
<Articles JournalTitle="Iranian Journal of Public Health">
    <Article>
        <Journal>
            <PublisherName>Kowsar</PublisherName>
            <JournalTitle>Gene Cell Tissue</JournalTitle>
            <Issn>2345-6833</Issn>
            <Volume>5</Volume>
            <Issue>4</Issue>
            <PubDate PubStatus="epublish">
                <Year>2019</Year>
                <Month>1</Month>
                <Day>13</Day>
            </PubDate>
            <journal_id_doi>10.5812/gct.84392</journal_id_doi>
        </Journal>
        <title locale="en_US">Evaluation of Additional &lt;i&gt;ABCC12&lt;/i&gt; Gene Expression Character in Breast Cancer Samples Using Formal Diagnostic Profile</title>
        <AuthorList>
            <Author>
                <FirstName>Maryam</FirstName>
                <LastName>Esmaeili</LastName>
                <affiliation locale="en_US">Department of Genetic, Islamic Azad University, Zanjan Branch, Zanjan, Iran</affiliation>
            </Author>
            <Author>
                <FirstName>Sina</FirstName>
                <LastName>Mirzaahmadi</LastName>
                <affiliation locale="en_US">Department of Genetic, Islamic Azad University, Zanjan Branch, Zanjan, Iran, Department of Genetic, Islamic Azad University, Zanjan Branch, Zanjan, Iran. Email:</affiliation>
            </Author>
            <Author>
                <FirstName>Golnaz</FirstName>
                <LastName>Asaadi Tehrani</LastName>
                <affiliation locale="en_US">Department of Genetic, Islamic Azad University, Zanjan Branch, Zanjan, Iran</affiliation>
            </Author>
        </AuthorList>
        <ArticleType>Research Article</ArticleType>
        <History>
            <PubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>1</Month>
                <Day>8</Day>
            </PubDate>
            <PubDate PubStatus="received">
                <Year>2018</Year>
                <Month>9</Month>
                <Day>18</Day>
            </PubDate>
            <PubDate PubStatus="epublish">
                <Year>2019</Year>
                <Month>1</Month>
                <Day>13</Day>
            </PubDate>
            <PubDate PubStatus="ppublish">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>31</Day>
            </PubDate>
        </History>
        <abstract locale="en_US">Background : Breast cancer (BC) is one of the most common cancers among women and is the main cause of cancer-related mortalities in the female population. The main cause of BC is not fully understood yet; however, many genes have been identified as risk factors that increase susceptibility to this disease. Objectives : The aim of this study was to evaluate the expression of 
        <i>ABCC12</i>gene in patients with ductal breast carcinoma and its relationship with other biomarkers including estrogen receptor (ER), progesterone receptor (RP) and human epidermal growth factor receptor 2 (
        <i>HER-2</i>). Methods : This study included nine women diagnosed with ductal breast carcinoma as cases and five healthy women as controls. RNA extraction from breast tissue and cDNA synthesis were performed, and the expression of 
        <i>ABCC12</i>gene was evaluated using the real time polymerase chain reaction (PCR) method. After preparing formalin-fixed paraffin-embedded breast tissues, immunohistochemical evaluation of these samples and chromogenic in situ hybridization (CISH) of ER, PR and 
        <i>HER-2</i>were performed. Results : The obtained results showed that the expression of 
        <i>ABCC12</i>gene in all the breast cancer tissues was 3.74 times higher than in controls (P = 0.007). Also, the expression of 
        <i>ABCC12</i>gene increased by 3.94 times in luminal B (P = 0.002), 3.54 times in 
        <i>HER-2</i>(1+) (P = 0.0006), 3.86 times in ER (+) (P = 0.002) and 3.63 times in PR (+) (P = 0.0005). Conclusions : Our study showed that the evaluation of the 
        <i>ABCC12</i>gene expression as a one of multi-drug resistance protein members can be used as a prognostic factor to identify the stages of BC and its therapeutic approaches.</abstract>
        <web_url>http://genecelltissue.com/en/articles/84392.html</web_url>
        <pdf_url>https://neoscriber.org/cdn/dl/370b025a-1976-11e9-aa7d-d7c4ef3ace81</pdf_url>
    </Article>
</Articles>
